“Structure of mammalian ornithine decarboxylase at 1.6 A resolution: stereochemical implications of PLP-dependent amino acid decarboxylases”. Structure7 (5): 567–81. (May 1999). doi:10.1016/S0969-2126(99)80073-2. PMID10378276.
“Characterization of the reaction mechanism for Trypanosoma brucei ornithine decarboxylase by multiwavelength stopped-flow spectroscopy”. Biochemistry36 (49): 15147–55. (December 1997). doi:10.1021/bi971652b. PMID9398243.
PDB: 1d7k; “Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding”. J. Mol. Biol.295 (1): 7–16. (January 2000). doi:10.1006/jmbi.1999.3331. PMID10623504.; rendered via PyMOL.
“Comparison of androgen regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase gene expression in rodent kidney and accessory sex organs”. Endocrinology130 (3): 1131–44. (March 1992). doi:10.1210/en.130.3.1131. PMID1537280.
“Ornithine decarboxylase induction and polyamine synthesis in the kindling of seizures: the effect of alpha-difluoromethylornithine”. Epilepsy Res.11 (1): 3–7. (1992). doi:10.1016/0920-1211(92)90015-L. PMID1563337.
“Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis”. Amino Acids33 (2): 359–66. (August 2007). doi:10.1007/s00726-007-0537-9. PMID17610127.
“Structure of mammalian ornithine decarboxylase at 1.6 A resolution: stereochemical implications of PLP-dependent amino acid decarboxylases”. Structure7 (5): 567–81. (May 1999). doi:10.1016/S0969-2126(99)80073-2. PMID10378276.
“Characterization of the reaction mechanism for Trypanosoma brucei ornithine decarboxylase by multiwavelength stopped-flow spectroscopy”. Biochemistry36 (49): 15147–55. (December 1997). doi:10.1021/bi971652b. PMID9398243.
PDB: 1d7k; “Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding”. J. Mol. Biol.295 (1): 7–16. (January 2000). doi:10.1006/jmbi.1999.3331. PMID10623504.; rendered via PyMOL.
“Role of asbestos and active oxygen species in activation and expression of ornithine decarboxylase in hamster tracheal epithelial cells”. Cancer Res.51 (1): 167–73. (January 1991). PMID1846307.
“Comparison of androgen regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase gene expression in rodent kidney and accessory sex organs”. Endocrinology130 (3): 1131–44. (March 1992). doi:10.1210/en.130.3.1131. PMID1537280.
“Development of difluoromethylornithine (DFMO) as a chemoprevention agent”. Clin. Cancer Res.5 (5): 945–51. (May 1999). PMID10353725.
“Ornithine decarboxylase induction and polyamine synthesis in the kindling of seizures: the effect of alpha-difluoromethylornithine”. Epilepsy Res.11 (1): 3–7. (1992). doi:10.1016/0920-1211(92)90015-L. PMID1563337.
“Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis”. Amino Acids33 (2): 359–66. (August 2007). doi:10.1007/s00726-007-0537-9. PMID17610127.
PDB: 1d7k; “Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding”. J. Mol. Biol.295 (1): 7–16. (January 2000). doi:10.1006/jmbi.1999.3331. PMID10623504.; rendered via PyMOL.
sourceforge.net
pymol.sourceforge.net
PDB: 1d7k; “Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding”. J. Mol. Biol.295 (1): 7–16. (January 2000). doi:10.1006/jmbi.1999.3331. PMID10623504.; rendered via PyMOL.